These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30825266)

  • 1. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
    Fan Z; Qin J; Wang D; Geng S
    J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.
    Gao D; Chen HQ
    Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
    Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
    J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
    Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
    Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
    Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
    J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.
    Viiklepp K; Nissinen L; Ojalill M; Riihilä P; Kallajoki M; Meri S; Heino J; Kähäri VM
    J Invest Dermatol; 2022 May; 142(5):1478-1488.e9. PubMed ID: 34756877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
    Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Grénman R; Peltonen S; Peltonen J; Pihlajaniemi T; Heljasvaara R; Kähäri VM
    Am J Pathol; 2017 May; 187(5):1186-1197. PubMed ID: 28322200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway.
    Jiang S; Liu H; Zhang J; Zhang F; Fan J; Liu Y
    Cancer Biol Ther; 2021 Jun; 22(5-6):381-391. PubMed ID: 34369270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma.
    Yuan S; Zhang P; Wen L; Jia S; Wu Y; Zhang Z; Guan L; Yu Z; Zhao L
    Oncogene; 2021 Sep; 40(39):5799-5813. PubMed ID: 34345013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS.
    Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y
    J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
    Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
    J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
    Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
    Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.